Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: Implications for HIV-1–associated neurocognitive disorder

References

• Abbott N (2002). Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200: 527.
   Google Scholar
• Aceijas C, Stimson GV, Hickman M, Rhodes T, United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18: 2295–2303.
   PubMed Web of Science ®Google Scholar
• Andras IE, Pu H, Deli MA, Nath A, Hennig B, Toborek M (2003). HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 74: 255–265.
   PubMed Web of Science ®Google Scholar
• Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789–1799.
   PubMed Web of Science ®Google Scholar
• Arese M, Ferrandi C, Primo L, Camussi G, Bussolino F (2001). HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment. J Immunol 166: 1380–1388.
   Google Scholar
• Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Greenberg RN, Berger JR (2004). Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol 157: 140–146.
   Web of Science ®Google Scholar
• Bagasra O, Pomerantz RJ (1993). Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis 168: 1157–1164.
   PubMed Web of Science ®Google Scholar
• Bayer BM, Mulroney SE, Hernandez MC, Ding XZ (1995). Acute infusions of cocaine result in time- and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacology 29: 19–28.
   PubMedGoogle Scholar
• Bazzoni G, Martinez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, Dejana E (2000). Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 275: 20520–20526.
   PubMed Web of Science ®Google Scholar
• Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261: 561–565.
   PubMed Web of Science ®Google Scholar
• Chao CC, Gekker G, Hu S, Sheng WS, Portoghese PS, Peterson PK (1995). Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem Pharmacol 50: 715–722.
   PubMed Web of Science ®Google Scholar
• Curran JW, Jaffe HW, Hardy AM, Morgan WM, Selik RM, Dondero TJ (1988). Epidemiology of HIV infection and AIDS in the United States. Science 239: 610–616.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Friedman SR (1988). The psychology of preventing AIDS among intravenous drug users. A social learning conceptualization. Am Psychol 43: 865–870.
   PubMed Web of Science ®Google Scholar
• Dhillon NK, Peng F, Bokhari S, Callen S, Shin SH, Zhu X, Kim KJ, Buch SJ (2008). Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIV-dementia. J Neuroimmune Pharmacol 3: 52–56.
   PubMed Web of Science ®Google Scholar
• Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C, Serrano Y, Inciardi JA, Bowser BP, Schilling RF, Holmberg SD (1994). Intersecting epidemics—crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med 331: 1422–1427.
   PubMed Web of Science ®Google Scholar
• Fiala AM, Gan XH, Newton T, Chiappelli F, Shapshak P, Kermani V, Kung MA, Diagne A, Martinez O, Way D, Weinand M, Witte M, Graves M (1996). Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages: HIV-1 enhancement by cocaine within the blood-brain barrier. Adv Exp Med Biol 402: 145–156.
   Google Scholar
• Gan X, Zhang L, Berger O, Stins MF, Way D, Taub DD, Chang SL, Kim KS, House SD, Weinand M, Witte M, Graves MC, Fiala M (1999). Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol 91: 68–76.
   PubMedGoogle Scholar
• Gandhi N, Saiyed Z, Thangavel S, Rodriguez J, Rao KV, Nair MP (2009). Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes. AIDS Res Hum Retroviruses 25: 691–699.
   PubMed Web of Science ®Google Scholar
• Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R (1997). The neuropathogenesis of the AIDS dementia complex. AIDS 11(Suppl A):S35–S45.
   Google Scholar
• Goodkin K, Wilkie FL, Concha M, Hinkin CH, Symes S, Baldewicz TT, Asthana D, Fujimura RK, Lee D, van Zuilen MH, Khamis I, Shapshak P, Eisdorfer C (2001). Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. J Clin Epidemiol 54(Suppl 1):S35–S43.
   PubMed Web of Science ®Google Scholar
• Hahn RA, Onorato IM, Jones TS, Dougherty J (1989). Prevalence of HIV infection among intravenous drug users in the United States. JAMA 261: 2677–2684.
   PubMed Web of Science ®Google Scholar
• Hamers FF, Batter V, Downs AM, Alix J, Cazein F, Brunet JB (1997). The HIV epidemic associated with injecting drug use in Europe: geographic and time trends. AIDS 11: 1365–1374.
   PubMedGoogle Scholar
• Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ (1995). The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1: 231–251.
   PubMedGoogle Scholar
• Heesch CM, Negus BH, Keffer JH, Snyder RW 2nd, Risser RC, Eichhorn EJ (1995). Effects of cocaine on cortisol secretion in humans. Am J Med Sci 310: 61–64.
   Google Scholar
• Hubbard RL, Marsden ME, Cavanaugh E, Rachal JV, Ginzburg HM (1988). Role of drug-abuse treatment in limiting the spread of AIDS. Rev Infect Dis 10: 377–384.
   PubMedGoogle Scholar
• Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y (2007). HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 27: 123–134.
   PubMed Web of Science ®Google Scholar
• Kaul M, Garden GA, Lipton SA (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988–994.
   PubMed Web of Science ®Google Scholar
• Kim TA, Avraham HK, Koh YH, Jiang S, Park IW, Avraham S (2003). HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J Immunol 170: 2629–2637.
   Web of Science ®Google Scholar
• Larrat EP, Zierler S (1993). Entangled epidemics: cocaine use and HIV disease. J Psychoactive Drugs 25: 207–221.
   PubMed Web of Science ®Google Scholar
• Lesniak MS, Brem H (2004). Targeted therapy for brain tumours. Nat Rev Drug Discov 3: 499–508.
   PubMed Web of Science ®Google Scholar
• Li W, Huang Y, Reid R, Steiner J, Malpica-Llanos T, Darden TA, Shankar SK, Mahadevan A, Satishchandra P, Nath A (2008). NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci 28: 12190–12198.
   PubMed Web of Science ®Google Scholar
• Luscinskas FW, Ma S, Nusrat A, Parkos CA, Shaw SK (2002). The role of endothelial cell lateral junctions during leukocyte trafficking. Immunol Rev 186: 57–67.
   Google Scholar
• Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Adal A, Qi M, Toh J, Xu G, Prasad PN, Schwartz SA (2008a). Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res 1203: 133–148.
   PubMed Web of Science ®Google Scholar
• Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Fernandez SF, Chawda R, Shanahan TC, Schwartz SA (2008b). Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability. J Clin Immunol 28: 528–541.
   Google Scholar
• McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP (1993). Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43: 2245–2252.
   PubMed Web of Science ®Google Scholar
• Mehta D, Malik AB (2006). Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279–367.
   PubMed Web of Science ®Google Scholar
• Mintz M (1994). Clinical comparison of adult and pediatric NeuroAIDS. Adv Neuroimmunol 4: 207–221.
   PubMedGoogle Scholar
• Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P (2008). Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann Neurol 63: 366–376.
   PubMed Web of Science ®Google Scholar
• Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT (2002). Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31(Suppl 2):S62–S69.
   Google Scholar
• Oshima T, Flores SC, Vaitaitis G, Coe LL, Joh T, Park JH, Zhu Y, Alexander B, Alexander JS (2000). HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways. AIDS 14: 475–482.
   Google Scholar
• Persidsky Y (1999). Model systems for studies of leukocyte migration across the blood-brain barrier. J NeuroVirol 5: 579–590.
   Web of Science ®Google Scholar
• Persidsky Y, Heilman D, Haorah J, Zelivyanskaya M, Persidsky R, Weber GA, Shimokawa H, Kaibuchi K, Ikezu T (2006). Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 107: 4770–4780.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Gekker G, Chao CC, Schut R, Molitor TW, Balfour HH Jr (1991). Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J Immunol 146: 81–84.
   PubMed Web of Science ®Google Scholar
• Peterson PK, Gekker G, Chao CC, Schut R, Verhoef J, Edelman CK, Erice A, Balfour HH Jr (1992). Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. J Immunol 149: 676–680.
   Google Scholar
• Peterson PK, Gekker G, Schut R, Hu S, Balfour HH Jr, Chao CC (1993). Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv Exp Med Biol 335: 181–188.
   Google Scholar
• Pu H, Tian J, Flora G, Lee YW, Nath A, Hennig B, Toborek M (2003). HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol Cell Neurosci 24: 224–237.
   PubMed Web of Science ®Google Scholar
• Ranga U, Shankarappa R, Siddappa NB, Ramakrishna L, Nagendran R, Mahalingam M, Mahadevan A, Jayasuryan N, Satishchandra P, Shankar SK, Prasad VR (2004). Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 78: 2586–2590.
   PubMed Web of Science ®Google Scholar
• Rao VR, Sas AR, Eugenin EA, Siddappa NB, Bimonte-Nelson H, Berman JW, Ranga U, Tyor WR, Prasad VR (2008). HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci 28: 10010–10016.
   PubMed Web of Science ®Google Scholar
• Robertson KR, Hall CD (1992). Human immunodeficiency virus-related cognitive impairment and the acquired immunodeficiency syndrome dementia complex. Semin Neurol 12: 18–27.
   PubMed Web of Science ®Google Scholar
• Samikkannu T, Saiyed ZM, Rao KV, Babu DK, Rodriguez JW, Papuashvili MN, Nair MP (2009). Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat protein. AIDS Res Hum Retroviruses 25: 329–335.
   Google Scholar
• Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, Desai A, Chandramuki A, Jayakumar PN, Shankar SK (2000). Profile of neurologic disorders associated with HIV/AIDS from Bangalore, South India (1989–96). Indian J Med Res 111: 14–23.
   PubMed Web of Science ®Google Scholar
• Shiu C, Barbier E, Di Cello F, Choi HJ, Stins M (2007). HIV-1 gp120 as well as alcohol affect blood-brain barrier permeability and stress fiber formation: involvement of reactive oxygen species. Alcohol Clin Exp Res 31: 130–137.
   PubMed Web of Science ®Google Scholar
• Toborek M, Lee YW, Flora G, Pu H, Andras IE, Wylegala E, Hennig B, Nath A (2005). Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol 25: 181–199.
   PubMed Web of Science ®Google Scholar
• Toborek M, Lee YW, Pu H, Malecki A, Flora G, Garrido R, Hennig B, Bauer HC, Nath A (2003). HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J Neurochem 84: 169–179.
   PubMed Web of Science ®Google Scholar
• Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, Nanivadekar A (2001). Neurological manifestations of HIV disease. J Assoc Physicians India 49: 343–348.
   PubMedGoogle Scholar
• White DA, Heaton RK, Monsch AU (1995). Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1: 304–315.
   PubMedGoogle Scholar
• Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT (2000). Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 97: 11466–11471.
   PubMed Web of Science ®Google Scholar
• Zhang L, Looney D, Taub D, Chang SL, Way D, Witte MH, Graves MC, Fiala M (1998). Cocaine opens the blood-brain barrier to HIV-1 invasion. J NeuroVirol 4: 619–626.
   PubMed Web of Science ®Google Scholar
• Zheng J, Gendelman HE (1997). The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 10: 319–325.
   PubMed Web of Science ®Google Scholar